Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

Fig. 2

Overall survival and progression-free survival in sporadic breast cancer. Kaplan-Meier estimates of overall probability of survival (b) and probability of progression-free survival (a) of EP3 positive and negative patient groups are displayed. Estimated survival rates are displayed at the end of each graph, p-values in the lower left corner. EP3 positivity was significantly associated with improved probability of progression-free survival (a) and improved overall probability of survival (b). yrs.: years, neg: negative, pos: positive

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us